Pay in 4 interest-free payments of $6.58 Learn more
Ships within 48 hours · Estimated delivery Oct 29 - Nov 3
Tirzepatide Significantly Reduced A1C and Body Weight in People with Type 2 Diabetes in Two Phase 3 Trials from Lilly's SURPASS Program INDIANAPOLIS, Feb
Tirzepatide enhances insulin secretion in a glucose-dependent manner, meaning it stimulates insulin release only when blood glucose levels are elevated, thereby reducing the risk of hypoglycaemia
Range of Treatment Options: Look for facilities offering a variety of oral and injectable medications, such as the Wegovy and Foundayo pills or Zepbound injections, to find the best fit for your lifestyle
This dual mechanism is why tirzepatide is sometimes described as a twincretin. It is FDA-approved under two brand names: Zepbound (for weight loss) and Mounjaro (for type 2 diabetes)
The peptides were not FDA-approved
US$ 21.83
US$ 20.89
US$ 21.71
